Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasms: A review

Advances in Anatomic Pathology

Volumn 16, Issue 6, 2009, Pages 383-391

  Tanas, Munir R ^a   Goldblum, John R ^a,b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Fluorescence in situ hybridization; Mesenchymal neoplasms; Soft tissue neoplasms

Indexed keywords

DNA; MELAN A; PROTEIN MDM2; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; CALMODULIN BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

CANCER DIAGNOSIS; CHONDROSARCOMA; CHROMOSOME TRANSLOCATION; CLEAR CELL SARCOMA; CYTOGENETICS; DERMATOFIBROSARCOMA PROTUBERANS; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; INTERMETHOD COMPARISON; LEIOMYOSARCOMA; LIPOSARCOMA; MELANOMA; MYXOSARCOMA; NERVE SHEATH TUMOR; NEUROECTODERM TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOMYOSARCOMA; SOFT TISSUE TUMOR; SPINDLE CELL SARCOMA; SYNOVIAL SARCOMA; CONNECTIVE TISSUE TUMOR; GENE TRANSLOCATION; GENETICS; LIPOMA; METHODOLOGY; SARCOMA; SMALL CELL SARCOMA;

CALMODULIN-BINDING PROTEINS; CHONDROSARCOMA; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOMA; LIPOSARCOMA; RHABDOMYOSARCOMA, ALVEOLAR; RNA-BINDING PROTEINS; SARCOMA; SARCOMA, CLEAR CELL; SARCOMA, EWING'S; SARCOMA, SMALL CELL; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 73949143761     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181bb6b86     Document Type: Review

References (30)

1. Tanas MR, Rubin BP, Tubbs RR, et al. Utilization of FISH in the diagnosis of 235 mesenchymal neoplasms: an institutional experience (Submitted for publication).
2. Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21: 943-949.
3. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer Genet Cytogenet. 2002;133:1-23.
4. Bridge RS, Rajaram V, Dehner LP, et al. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely process tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol. 2006; 19:1-8.
5. Nishio J, Althof PA, Bailey JM, et al. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest. 2006;86:547-556.
6. Barr FG, Chatten J, D'Cruz CM, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcoma. JAMA. 1995;273:553-557.
7. Downing JR, Khandeker A, Shurtleff SA, et al. Multiplex RTPCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. Am J Pathol. 1995;146: 626-634.
8. Arden KC, Anderson MJ, Finckenstain FG, et al. Detection of the t(2;13) translocation in alveolar rhabdomyosarcoma using the reverse transcriptase-chain reaction. Genes Chromosomes Cancer. 1996;16:254-260.
9. de Alava E, Ladanyi M, Rosai J, et al. Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction: a specific diagnostic assay. Am J Pathol. 1995;147:1584-1591.
10. Gibas Z, Miettinen M, Limon J, et al. Cytogenetic and immunohistochemical studies were performed in nine myxoid liposarcomas. Am J Clin Pathol. 1995;103:20-26.
11. Knight JC, Renwick PJ, Dal Cin P, et al. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995;55:24-27.
12. Panagopoulos I, Hoglund M, Mertens F, et al. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene. 1996;12:489-494.
13. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. Philadelphia: Elsevier; 2008.
14. Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res. 2003;63:4568-4576.
15. Ng TL, O'Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn. 2007;9:459-463.
16. Rubin BP, Lazar AJF, Oliveira AM. Molecular pathology of bone and soft tissue tumors. In: Tubbs RR, Stoler MH, eds. Cell and Tissue Based Molecular Pathology. Philadelphia: Elsevier; 2009:325-359.
17. Panagopoulos I, Merten F, Isaksson M, et al. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer. 2002;35:340-35:352.
18. Smith TA, Machen SK, Fisher C, et al. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor. Am J Clin Pathol. 1999;112:641-648.
19. Storlazzi CT, Mertens F, Mandahl N, et al. A novel fusion gene; SS18L1/SSX1 in synovial sarcoma. Genes Chromosomes Cancer. 2003;37:195-200.
20. Coindre JM, Hostein I, Benhattar J, et al. Malignant peripheral nerve sheath tumors are t(X;18)-negative sarcomas. Molecular analysis of 25 cases occurring in neurofibromatosis type I patients, using two different RT-PCR-based methods of detection. Mod Pathol. 2002;15:589-592.
21. Guillou L, Benhattar J, Gengler C, et al. Translocationpositive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French sarcoma group. Am J Surg Pathol. 2007;31:1387-1402.
22. Reid R, de Silva MV, Paterson L, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol. 2003;27:1229-1236.
23. Mertens F, Fletcher CD, Antonescu CR, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85:408-415.
24. Fletcher CDM, Akerman M, Dal Cin P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors: a report of 178 cases from the chromosomes and morphologic (CHAMP) collaborative study group. Am J Pathol. 1996;148:623-630.
25. Rosai J, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP study group). Am J Surg Pathol. 1996;20:1182-1189.
26. Sirvent N, Coindre JM, Maire G, et al. Detection of MDM2CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol. 2007;31: 1476-1489.
27. Nascimento AG. Dedifferentiated liposarcoma. Semin Diagn Pathol. 2001;18:263-266.
28. Coindre JM, Hostein I, Terrier P, et al. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissue: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group. Cancer. 2006;107:1055-1064.
29. Patel RM, Downs-Kelly E, Weiss SW, et al. Dual-color break apart fluorescent in situ hybridization for EWS rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol. 2005;18:1585-1590.
30. Antonescu CR, Dal Cin P, Nafa K, et al. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007;46:1051-1060.